Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form
As of April 1st VIVO Scientific Profiles will no longer updated for faculty, and the link to VIVO will be removed from the library website. Faculty profile pages will continue to be updated via Interfolio. VIVO will continue being used behind the scenes to update graduate student profiles. Please contact helplib@scripps.edu if you have questions.
How to download citations from VIVO | Alternative profile options

Regulation of adipogenesis by natural and synthetic REV-ERB ligands

Academic Article
uri icon
  • Overview
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

related to degree

  • Crumbley, Christine, Ph.D. in Biology, Scripps Research 2009 - 2012

authors

  • Kumar, N.
  • Solt, Laura A.
  • Wang, Y. J.
  • Rogers, P. M.
  • Bhattacharyya, G.
  • Kamenecka, Theodore
  • Stayrook, K. R.
  • Crumbley, Christine
  • Floyd, Z. E.
  • Gimble, J. M.
  • Griffin, Patrick
  • Burris, Thomas

publication date

  • July 2010

journal

  • Endocrinology  Journal

abstract

  • The nuclear hormone receptor, REV-ERB, plays an essential role in adipogenesis. Rev-erbalpha expression is induced in 3T3-L1 cells during adipogenesis, and overexpression of this receptor leads to expression of adipogenic genes. We recently demonstrated that the porphyrin heme functions as a ligand for REV-ERB, and binding of heme is required for the receptor's activity. We therefore hypothesized that REV-ERB ligands may play a role in regulation of adipogenesis. We detected an increase intracellular heme levels during 3T3-L1 adipogenesis that correlated with induction of aminolevulinic acid synthase 1 (Alas1) expression, the rate-limiting enzyme in heme biosynthesis. If the increase in Alas1 expression was blocked, adipogenesis was severely attenuated, indicating that induction of expression of Alas1 and the increase in heme synthesis is critical for differentiation. Inhibition of heme synthesis during adipogenesis leads to decreased recruitment of nuclear receptor corepressor to the promoter of a REV-ERB target gene, suggesting alteration of REV-ERB activity. Treatment of 3T3-L1 cells with a synthetic REV-ERB ligand, SR6452, resulted in induction of adipocyte differentiation to a similar extent as treatment with the peroxisomal proliferator-activated receptor-gamma agonist, rosiglitazone. Combination of SR6452 and rosiglitazone had an additive effect on stimulation of adipocyte differentiation. These results suggest that heme, functioning as a REV-ERB ligand, is an important signaling molecule for induction of adipogenesis. Moreover, synthetic small molecule ligands for REV-ERB are effective modulators of adipogenesis and may be useful for treatment of metabolic diseases.

subject areas

  • 3T3-L1 Cells
  • 5-Aminolevulinate Synthetase
  • Adipogenesis
  • Animals
  • Blotting, Western
  • Cell Differentiation
  • Chromatin Immunoprecipitation
  • Heme
  • Ligands
  • Mice
  • Nuclear Receptor Subfamily 1, Group D, Member 1
  • RNA, Small Interfering
  • Thiazolidinediones
scroll to property group menus

Identity

PubMed Central ID

  • PMC2903944

International Standard Serial Number (ISSN)

  • 0013-7227

Digital Object Identifier (DOI)

  • 10.1210/en.2009-0800

PubMed ID

  • 20427485
scroll to property group menus

Additional Document Info

start page

  • 3015

end page

  • 3025

volume

  • 151

issue

  • 7

©2022 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support